Company US Rare Earth Minerals Inc Other OTC
Equities
US9034101082
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
19/04 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | Bioxytran, Inc. Announces Board Changes | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 01/18/01 |
Ola Soderquist
DFI | Director of Finance/CFO | 63 | - |
Leslie Ajayi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Sheikh
IRO | Public Communications Contact | 54 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 01/18/01 |
Dale Conaway
BRD | Director/Board Member | 69 | 02/18/02 |
Anders Utter
BRD | Director/Board Member | 57 | 02/18/02 |
Alan Hoberman
BRD | Director/Board Member | 71 | 02/18/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 174,962,481 | 75,447,287 ( 43.12 %) | 0 | 43.12 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- BIXT Stock
- Stock
- Company US Rare Earth Minerals Inc